Antitumor Potential of Sericite Treatment Mediated by Cell Cycle Arrest in Triple-Negative MDA-MB231 Breast Cancer Cells

Breast cancer is the most common cancer and the leading cause of cancer-related mortality among females worldwide. Triple-negative breast cancer (TNBC) accounts for about 10–15% of all breast cancers and is usually more aggressive and has a poorer prognosis. Sericite has been known to have antitumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seonhee, Nagar, Harsha, Lee, Ikjun, Choi, Su-Jeong, Piao, Shuyu, Jeon, Byeong Hwa, Kang, Shin Kwang, Song, Hee-Jung, Kim, Cuk-Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527418/
https://www.ncbi.nlm.nih.gov/pubmed/36199546
http://dx.doi.org/10.1155/2022/2885293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527418/
https://www.ncbi.nlm.nih.gov/pubmed/36199546
http://dx.doi.org/10.1155/2022/2885293

Ejemplares similares